August 2015

Phase 1 Study of dmLT ID Vaccination in Healthy Adults

Condition:   Gastroenteritis Escherichia Coli
Interventions:   Other: Placebo;   Biological: Recombinant Double Mutant Heat-Labile Toxin LT(R192G/L211A) (dmLT) Oral entertoxigenic Escherichia coli (ETEC) Vaccine
Sponsor:   National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - verified January 2017

Enterotoxigenic Escherichia Coli (ETEC) ETVAX Vaccine Trial in Bangladesh

Condition:   Escherichia Coli Diarrhea
Interventions:   Biological: ETVAX;   Biological: dmLT;   Other: Sodium Bicarbonate Buffer
Sponsors:   PATH;   Scandinavian BioPharma;   International Centre for Diarrhoeal Disease Research, Bangladesh
Recruiting - verified May 2016